Enhancing the evaluation of PI3K inhibitors through 3D melanoma models

Targeted therapies for mutant BRAF metastatic melanoma are effective but not curative due to acquisition of resistance. PI3K signaling is a common mediator of therapy resistance in melanoma; thus, the need for effective PI3K inhibitors is critical. However, testing PI3K inhibitors in adherent cultur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pigment Cell Melanoma Res
Main Authors: Shannan, Batool, Chen, Quan, Watters, Andrea, Perego, Michela, Krepler, Clemens, Thombre, Rakhee, Li, Ling, Rajan, Geena, Peterson, Scott, Gimotty, Phyllis A., Wilson, Melissa, Nathanson, Katherine L., Gangadhar, Tara C., Schuchter, Lynn M., Weeraratna, Ashani T., Herlyn, Meenhard, Vultur, Adina
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840066/
https://ncbi.nlm.nih.gov/pubmed/26850518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados